-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$13.50121.31% Upside
C4 Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover C4 Therapeutics, Inc.?
C4 Therapeutics, Inc. has been rated by research analysts at BMO Capital, Wells Fargo, Credit Suisse, Bank of America Securities in the past 90 days.